Five-pronged strategy hoped to offer relief to U.S. farmers and consumers.

PirA or PirB binding nanobodies protect whiteleg shrimp from acute hepatopancreatic necrosis disease and replace antibiotics

NovoBind develops next-generation biologics using nanobodies that attack disease